|
|
|
 |
|
|
 |
 |
Insmed Incorporated
Company
Snapshot Purchase a Full Report on this Company
Business Description:
Insmed Incorporated. The Group's principal activities are developing and marketing pharmaceutical products for the treatment of metabolic, hormone growth disorders, diabetes and endocrine disorders. It has three drug candidates IPLEX, rhIGFBP-3 and INSM-18. IPLEX is used for the treatment of growth failure in children with severe primary IGF-1 deficiency or with growth hormone gene deletion. INSM-18 and rhIGFBP-3 is used for the treatment of cancer which is in clinical development. These drugs are developed to treat indications in the metabolic and oncology fields it also correct metabolic defects in the human body by replacing key regulatory molecules in a physiologically relevant fashion.
|
|
| |
Wright Quality Rating:
DBNN Rating Explanations |
| |
|
| |
|
| |
|
|
|
|
|
|
| |
| |
Stock Data: |
Recent Stock Performance: |
|
| |
Current Price (2/5/2010):
.83
(Figures in
U.S. Dollars) |
|
1 Week |
-0.4% |
|
13 Weeks |
7.8% |
|
|
|
|
|
|
|
|
|
4 Weeks |
7.8% |
|
52 Weeks |
88.7% |
|
|
|
| |
| |
Insmed Incorporated
Key Data: |
|
|
|
| |
Ticker: |
INSM |
Country: |
UNITED STATES |
| |
|
| |
Exchanges: |
NAS |
Major Industry: |
Drugs, Cosmetics & Health Care |
| |
|
| |
|
|
Sub Industry: |
Ethical Drug Manufacturers |
| |
|
| |
2008
Sales |
11,699,000
(Year Ending Jan 2009). |
Employees: |
97 |
| |
|
| |
Currency: |
U.S. Dollars |
Market Cap: |
108,072,722 |
| |
|
| |
Fiscal Yr Ends: |
December |
Shares Outstanding: |
130,208,099 |
| |
|
| |
Share Type: |
Common |
Closely Held Shares: |
2,136,145 |
|
| |
|
| |
| |
|
|
|
|
| |
Purchase a Full Subscription to All Reports From CorporateInformation: |
|
|
|
| |
The following reports, available for Insmed Incorporated, are typical of the content provided on all companies
covered in CorporateInformation.com
Basic Reports
Insmed Incorporated company Profile (Business Description, Price/Earnings, Price/Sales,
Price/Book, Dividend Yield, Company Officers, Contact Information), Competitor Analysis and up to ten-year history of Sales, Earnings per Share,
Dividends per Share, Security Price and Key Ratios. View Samples
Financial Statement Reports
Research reports that analyze Insmed Incorporated Income Statement and Balance Sheet along with
the Sources of Capital for a five-year period. View Samples
Financial Ratio Reports
Analyses reports that highlight Insmed Incorporated
Accounting Ratios, Asset Utilization, Fixed Charges Coverage, Liquidity, Leverage, Profitability,
Employee Efficiency and Per-Share Data over a five-year period. View Samples
Wright Quality Analyses Reports
Wright’s proprietary rating of corporate quality. The reports include a detailed
analysis of Insmed Incorporated Equity, Liquidity, Financial Strength,
Profitability and Corporate Growth. View Samples |
| |
|
|
| |
|
|
|
 |
|
|
|
|
|
|
|
CorporateInformation® website and selected data Copyright © 2000 -
by The Winthrop Corporation. All Rights Reserved. Except for quotations by established
news media, no pages on this site may be reproduced, stored in a retrieval system,
or transmitted for commercial purposes, in any form or by any means, electronic,
mechanical, photocopying, recording, or otherwise without prior written permission.
Information is believed reliable, but accuracy, completeness and opinions are not
guaranteed.
|
|
|
|